0415SP |
Chlorophacinone (Qualitative), Serum/Plasma |
0985B |
Carbinoxamine, Blood |
1040B |
Cetirizine, Blood |
1040SP |
Cetirizine, Serum/Plasma |
1040U |
Cetirizine, Urine |
1044B |
Chloral Hydrate, Blood |
1044SP |
Chloral Hydrate, Serum/Plasma |
1190B |
Chlorpheniramine, Blood |
1190SP |
Chlorpheniramine, Serum/Plasma |
1190U |
Chlorpheniramine, Urine |
1270B |
Clonazepam and Metabolite, Blood |
1270FL |
Clonazepam and Metabolite, Fluid |
1270SP |
Clonazepam and Metabolite, Serum/Plasma |
1270TI |
Clonazepam and Metabolite, Tissue |
1270U |
Clonazepam as Metabolite, Urine |
1280U |
Clorazepate as Metabolite, Urine |
1425B |
Cyproheptadine, Blood |
1425SP |
Cyproheptadine, Serum/Plasma |
1425U |
Cyproheptadine, Urine |
9139B |
Clonazepam and Metabolite Screen, Blood |
9139FL |
Clonazepam and Metabolite Screen, Fluid |
9139SP |
Clonazepam and Metabolite Screen, Serum/Plasma |
9139U |
Clonazepam as Metabolite Screen, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |